“…ORB has been shown to inhibit reversibly the synthesis of heterogeneous nuclear RNA (hnRNA) in mammalian cells but, although it is now widely used as a tool for studying early events in transcription (Skolnik-David et al, 1982;Tweeten and Molloy, 1982;Mukherjee and Molloy, 1987;Barettino et al, 1988;Chaly et el., 1988;Gallinaro et el., 1988;Chodosh et el., 1989), its mechanism of action remains unclear (Zandomeni et al, 1983). Recently it has been proposed that the target of ORB inhibition could be casein kinase II (Zandomeni and Weinmann, 1984;Holst and Egyhazi, 1985;Zandomeni et el., 1986;Stevens and Maupin, 1989;Zandomeni, 1989;Meggio et aI., 1990;Dobrowolska et el., 1991), an enzyme involved in the regulation of mRNA transcription in eukaryotic systems via phosphorylation of subunits of RNA polymerase II and/or transcription factors (Horikoshi et ei., 1987;Paynet et al, 1989). Furthermore, it has been demonstrated that ORB is transported across the plasma membrane into cells by facilitated diffusion, and it is efficiently metabolized to its 2'-and 5'-monophosphates (Egyhazi et al, 1980).…”